The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFarland, H. I.
Right arrow Articles by Lenardo, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFarland, H. I.
Right arrow Articles by Lenardo, M. J.
The Journal of Immunology, 2001, 166: 2116-2121.
Copyright © 2001 by The American Association of Immunologists

Effective Antigen-Specific Immunotherapy in the Marmoset Model of Multiple Sclerosis

Hugh I. McFarland1,*, Adrian A. Lobito*, Michele M. Johnson*, Gregory R. Palardy*, Christina S. K. Yee*, E. Kay Jordan{dagger}, Joseph A. Frank{dagger}, Nancy Tresser{ddagger}, Claude P. Genain§, John P. Mueller2, Louis A. Matis and Michael J. Lenardo3,*

* Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; {dagger} Laboratory of Diagnostic Radiology Research and {ddagger} Neuroimmunology Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD 20892; § Department of Neurology, University of California, San Francisco, CA 94143; and Alexion Pharmaceuticals, Inc., New Haven, CT 06511

Mature T cells initially respond to Ag by activation and expansion, but high and repeated doses of Ag cause programmed cell death and can suppress T cell-mediated diseases in rodents. We evaluated repeated systemic Ag administration in a marmoset model of experimental allergic encephalomyelitis that closely resembles the human disease multiple sclerosis. We found that treatment with MP4, a chimeric, recombinant polypeptide containing human myelin basic protein and human proteolipid protein epitopes, prevented clinical symptoms and did not exacerbate disease. CNS lesions were also reduced as assessed in vivo by magnetic resonance imaging. Thus, specific Ag-directed therapy can be effective and nontoxic in primates.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Odoardi, N. Kawakami, Z. Li, C. Cordiglieri, K. Streyl, M. Nosov, W. E. F. Klinkert, J. W. Ellwart, J. Bauer, H. Lassmann, et al.
Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis
PNAS, January 16, 2007; 104(3): 920 - 925.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. D. Lutton, R. Winston, and T. C. Rodman
Multiple Sclerosis: Etiological Mechanisms and Future Directions
Experimental Biology and Medicine, January 1, 2004; 229(1): 12 - 20.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.